StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > The thesis has changed.

<< Previous

Bullboard Posts

Next >>

Comment by LithLoveron Jul 21, 2021 12:16pm

145 Views

Post# 33581573

RE:RE:RE:RE:RE:RE:The thesis has changed.

someone is hungry. Just quietly buying more shares to get to 2 million. Nothing too big to move the share price just quiet accumulation now why would that be?

11:49:29

0.405

0.01

6,000

22 Fidelity

2 RBC

LithLover wrote: Tasty treats

11:49:29 U 0.405 0.01 6,500 22 Fidelity 2 RBC

LithLover wrote: nom nom nom

11:05:02 T 0.405 0.01 10,000 22 Fidelity 33 Canaccord

Mykndrsn wrote: Facts mean nothing to the clueless Stock Scout X. I assume I - IX were just as clueless.